Center for Rett syndrome, Department of Paediatrics and Adolescents Medicine
Copenhagen, København Ø, 2100, Denmark
NCT Number: NCT03848442
The aim of the study is to evaluate the feasibility and health-related effects of an individualized 12wk 'uptime' participation intervention in girls and women with Rett syndrome. Girls and women above 5 years of age with Rett syndrome and a confirmed MECP2 mutation will be included. Each individual program focuses on participation in enjoyable activities to promote 'uptime' in home, school/day center and community settings. Primary outcomes are sedentary time and daily steps. Secondary outcomes are gross motor skills, walking capacity, quality of life and participation-level goals. Outcomes are evaluated on four occasions: at baseline and after a 6-week interval, immediately following the 12-week intervention program and 12 weeks after the intervention program.
Looking for future studies?
Notify Me5 year and older
Female
Interventional
Not applicable
Copenhagen, København Ø, 2100, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention are designed for each individual and are consistent with the model for participation-based interventions. The interventions are goal-oriented (meaningful and family/client-selected goals), family/client-centered (promoted self-determination and decision making), collaborative (partnership between caregivers), strength-based (built on participant and caregiver strengths) and ecological (natural environment and real-life experiences). Design of the intervention comprised three steps: 1) Preparation period (6 weeks); 2) Intervention period (12 weeks); 3) Follow-up period (12 weeks)
Time frame: Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up
Change in sedentary time
Time frame: Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up
Change in daily step count
Time frame: Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up
Change in gross motor skills
Time frame: Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up
Change in walking capacity
Time frame: Assessed four times; twice at baseline; once after the 12 week intervention and once after a further 12 week follow-up
Change in quality of life. The Quality of Life Inventory-Disability was used to assess quality of life. This 32 item-questionnaire was developed for children 5-18 years of age with ID. Responses are used to calculate an overall score and six subscale scores (social interaction, positive emotions, physical health, negative emotions, leisure/outdoors and independence), each scored on a 0-100 scale with higher scores representing better quality of life.
Time frame: Assessed twice; at baseline and after the 12 week intervention
Change in participation level goals. Goal attainment scaling is a validated method for evaluating achievement of individual goals. Individual goals were assessed on a five-point rating scale ranging from -2 to +2. Baseline was set at -2, the expected level after the intervention at zero and the most favorable outcome at +2. The goals were graded in relation to frequency or duration of an activity.
Rigshospitalet, Denmark
Other
Feasibility and Effectiveness of an Individualized 12-week 'Uptime' Participation Intervention (U-PART) in Girls and Women With Rett Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06199700
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Xiamen, Fujian, China
View Trial DetailsNCT06849973
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
La Jolla, California, United States
View Trial DetailsNCT04514549
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Boston, Massachusetts, United States
View Trial DetailsNCT03633058
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Birmingham, Alabama, United States
View Trial Details